CS logo
small CS logo
Kantonsspital Frauenfeld / Brustzentrum Thurgau

Frauenfeld, Switzerland
Doctor in Frauenfeld
Pfaffenholzstrasse 4, 8500 Frauenfeld

About Kantonsspital Frauenfeld / Brustzentrum Thurgau


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Swiss Group for Clinical Cancer Research
6
ETOP IBCSG Partners Foundation
1
University Hospital, Basel, Switzerland
1
Total Rows: 3

Clinical Trials at Kantonsspital Frauenfeld / Brustzentrum Thurgau


During the past decade, Kantonsspital Frauenfeld / Brustzentrum Thurgau conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11110011110000000011Started TrialsCompleted Trails2015201620172018201900.511.5
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Fulvestrant With or Without AZD6244 in Treating Patients With Advanced Breast Cancer That Progressed After Aromatase Inhibitor Therapy
2010-08-01
2016-09-01
Completed
46
Trastuzumab & Pertuzumab Followed by T-DM1 in MBC
2013-03-03
2020-05-26
Completed
208
Adjuvant Treatment Recommendation and Oncotype DX® in Early Breast Cancer
2013-09-01
2015-02-01
Completed
229
CR1447 in Endocrine Responsive-HER2neg and TN-ARpos Breast Cancer
2016-06-14
2027-06-01
Active, not recruiting
29
Eribulin as 1st Line Treatment in Elderly Patients With Advanced Breast Cancer
2015-08-17
2021-07-22
Terminated
78
Tailored Axillary Surgery With or Without Axillary Lymph Node Dissection Followed by Radiotherapy in Patients With Clinically Node-positive Breast Cancer (TAXIS)
2018-08-07
2036-12-01
Recruiting
1,500
Activity Program During Aromatase Inhibitor Therapy
2019-03-28
2025-12-01
Active, not recruiting
375

Rows per page:

1–8 of 8

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Kantonsspital Frauenfeld / Brustzentrum Thurgau" #1 collaborator was "Austrian Breast Cancer Study Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading SponsorsSwiss Group for ClinicalCancer Research: 6Swiss Group for ClinicalCancer Research: 6ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1University Hospital,Basel, Switzerland: 1University Hospital,Basel, Switzerland: 1

Created with Highcharts 11.1.0Top CollaboratorsAustrian Breast CancerStudy Group: 1Austrian Breast CancerStudy Group: 1Breast International Group: 1Breast International Group: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1

Clinical Trials Conditions at Kantonsspital Frauenfeld / Brustzentrum Thurgau


According to Clinical.Site data, the most researched conditions in "Kantonsspital Frauenfeld / Brustzentrum Thurgau" are "Breast Cancer" (5 trials), "Adenocarcinoma" (1 trials), "Early Breast Cancer" (1 trials), "Metastatic Breast Adenocarcinoma" (1 trials) and "Metastatic Breast Cancer" (1 trials). Many other conditions were trialed in "Kantonsspital Frauenfeld / Brustzentrum Thurgau" in a lesser frequency.

Clinical Trials Intervention Types at Kantonsspital Frauenfeld / Brustzentrum Thurgau


Most popular intervention types in "Kantonsspital Frauenfeld / Brustzentrum Thurgau" are "Drug" (5 trials), "Behavioral" (1 trials), "Procedure" (1 trials) and "Radiation" (1 trials). Other intervention types were less common.
The name of intervention was led by "Activity program" (1 trials), "CR1447" (1 trials), "Control" (1 trials), "Eribulin mesilate" (1 trials) and "Letrozole" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Kantonsspital Frauenfeld / Brustzentrum Thurgau


The vast majority of trials in "Kantonsspital Frauenfeld / Brustzentrum Thurgau" are 7 trials for "Female" genders and 1 trials for "All" genders.

Clinical Trials Status at Kantonsspital Frauenfeld / Brustzentrum Thurgau


Currently, there are NaN active trials in "Kantonsspital Frauenfeld / Brustzentrum Thurgau". undefined are not yet recruiting, 1 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kantonsspital Frauenfeld / Brustzentrum Thurgau, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Kantonsspital Frauenfeld / Brustzentrum Thurgau, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 4Phase 2: 4Not Applicable: 2Not Applicable: 2Phase 3: 1Phase 3: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 4Completed: 4Active, not recruiting: 2Active, not recruiting: 2Recruiting: 1Recruiting: 1Terminated: 1Terminated: 1